Latest News, Newsletter

Cleveland Clinic Announced as Pheo Para Center of Excellence

November 8, 2021

Pheo Para Alliance has designated Cleveland Clinic’s Multidisciplinary Adrenal and Neuroendocrine Tumor Center as a Center of Excellence. Pheo Para Alliance is a patient advocacy organization dedicated to supporting those with pheochromocytoma (pheo) and paraganglioma (para), a rare neuroendocrine tumor. The Center of Excellence Program recognizes institutions worldwide for providing cutting-edge, quality, multidisciplinary care and participating in pheo- and para-related research.

Eli Soto, Chair of the Pheo Para Alliance Board of Directors, states, “the foundation of the Center of Excellence program is to provide hope and empower patients by sharing information about stellar programs with a focus on exceptional clinical care and finding answers through research. Cleveland Clinic’s Multidisciplinary Adrenal and Neuroendocrine Tumor Center is a wonderful addition to the Center of Excellence program.”

Eren Berber, M.D., endocrine surgeon and director of Cleveland Clinic’s Multidisciplinary Adrenal and Neuroendocrine Tumor Center, says, “We put patients first and strive to provide exceptional patient care with compassion. Our center includes pheochromocytoma experts across multiple specialties.”

Cleveland Clinic’s Multidisciplinary Adrenal and Neuroendocrine Tumor Center has been established by the Endocrinology & Metabolism Institute and is dedicated to adrenal tumors and disorders. The center’s multidisciplinary team includes specialists from genomic medicine, nuclear medicine, diagnostic imaging, pediatric endocrinology, oncology, and more.